drugset / Trial / NCT05742126
A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Dosed of HSK36273 in Healthy Volunteers
RandomizedParallel-groupDouble-blindOther
Summary
This is a single-center, Phase 1, placebo and positive-controlled, randomized, partial-blind, integrated, sequential ascending dose / multiple ascending dose study.The safety, tolerability, pharmacokinetics and pharmacodynamics of multiple continuous IV infusion ascending doses of HSK36273 in healthy volunteers will be evaluated.
Timeline
- Start
- 2022-04-11
- Primary completion
- 2022-09-12
- Completion
- 2022-09-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HSK36273 | Unknown | — | Intravenous |
| Comparator | Heparin sodium injection | Unknown | — | — |
Indications
No indication recorded.